GlassScriptPhysician profile
Emily Sapp
NPI 1619519303
$1,438.96
in general payments reported to CMS, 2019-2025
13 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $300 · 2022: $760 · 2023: $204 · 2024: $20.56 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $378.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $295.25 | 2021-2025 | |
| Boston Scientific Corporation | $182.72 | 2021-2024 | Wavewriter Alpha Prime 16 |
| Globus Medical, INC. | $165.11 | 2023 | Excelsiusgps Robotic Navigation System, Creo 5.5 |
| Stryker Corporation | $162.31 | 2022 | |
| Nevro Corp. | $142.35 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $137.94 | 2022 | |
| Collegium Pharmaceutical, INC. | $137.64 | 2022 | |
| Amgen INC. | $82.68 | 2025 | |
| Radius Health, INC. | $42.23 | 2025 | Tymlos |
| Lundbeck LLC | $25.60 | 2022 | |
| Grt US Holding, INC. | $23.41 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $22.03 | 2022 | |
| Scilex Pharmaceuticals INC. | $19.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Sapp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.